Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07324785

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

The Role and Mechanism of SphK1/S1P/FOXO1 Axis Regulating KATP Channel Mediated Gastric Smooth Muscle Dysfunction in Diabetes Gastroparesis

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Northern Jiangsu People's Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective observational study. The study will explore the correlation between advanced glycation end products and gastric motility disorder in diabetic gastroparesis(DGP) through the collection of blood and gastric tissue samples and relevant data of patients with DGP and control group patients without diabetes history and gastroparesis symptoms.

Detailed description

This study will collect the gastric smooth muscle tissue and serum of patients with diabetic gastroparesis(DGP) and control group patients without diabetes history and gastroparesis symptoms, and collect the following patient related information: age, gender, height, weight, fasting blood glucose, diabetes course, glycosylated hemoglobin, fasting C-peptide, serum creatinine, and electrogastrogram results. The study will compare the score of gastroparesis cardinal symptom index scale and electrogastrogram results of patients with DGP and and control group patients without diabetes history and gastroparesis symptoms, detect and compare the difference in the expression of contractile protein in the muscle layer of gastric tissue of the two groups, detect and compare the difference in advanced glycation end products (AGEs) of serum and gastric tissue of the two groups, and analyze the correlation between serum and gastric tissue AGEs and clinical symptoms. Through the above results, we will clarify the correlation between AGEs and gastric motility disorders in DGP.

Conditions

Timeline

Start date
2026-01-07
Primary completion
2027-05-31
Completion
2027-05-31
First posted
2026-01-07
Last updated
2026-02-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07324785. Inclusion in this directory is not an endorsement.